Clonorchiasis Market Opportunities, Current Trends And Restraints Forecast 2023
Clonorchiasis Market Synopsis:
Clonorchiasis is infection with the liver fluke Clonorchis
sinensis caused due to eating undercooked freshwater fish. Chronic cholangitis
in heavy infections, which may progress to atrophy of liver parenchyma, portal
fibrosis, and cirrhosis. Increasing prevalence of clonorchiasis, changing
lifestyle, poor diet, and increasing geriatric population have driven the
growth of the market. Moreover, increasing healthcare expenditure has fuelled
the growth of the market. On the other hand, high cost of the treatment may
slow the market growth.
The global clonorchiasis market is expected to grow
at a CAGR of 5.4% during the forecast period.
Clonorchiasis is an infectious disease caused by the
Chinese liver fluke Clonorchis sinensis. Clonorchiasis is dominant in Asian
countries and regions, including South Korea, China, Northern Vietnam, and
far-eastern Russia. China has the largest population of infected people. In the
acute phase, heavier infections can cause fever, chills, epigastric pain,
tender hepatomegaly, mild jaundice, and eosinophilia occur.
Get Free Sample Copy at https://www.marketresearchfuture.com/sample_request/4686
Major Players in Market
The key players for the global clonorchiasis market are –
- Pfizer (U.S)
- Bayer AG (Germany)
- Provet (Switzerland)
- Virbac (India)
- Cipla (India)
- Novartis AG (Switzerland)
- CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India)
- Merck & Co. Inc. (U.S.)
- Hoffmann-La Roche Ltd. (Switzerland)
- Abbott (U.S.)
- Arsanis Inc. (Austria)
- Novabiotics (U.K.)
- GlaxoSmithKline plc. (U.K.)
- Teva Pharmaceutical Industries Ltd (Taiwan).
Segmentation
The global clonorchiasis market is segmented on the basis
of parasites, therapy, and end users.
On the basis of the parasites, the market is segmented into Clonorchis sinensis, Opisthorchis
viverrini, Opisthorchis felineus, and others.
On the basis of the therapy,
the market is segmented into diagnosis and treatment. The diagnosis is further
segmented into microscopic examination, X-ray, serologic tests, and others. The
treatment is sub-segmented into praziquantel, cesol, cisticid, biltricide, and
others.
On the basis of end users,
the market is segmented into hospital, clinics, and others.
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Brows Complete Premium Research at https://www.marketresearchfuture.com/reports/clonorchiasis-market-4686
Regional Analysis
The Americas dominate the global clonorchiasis market owing
to a large geriatric population, strong government support for research &
development, and high healthcare spending. According to the Centers for Disease
Control and Prevention in 2014, over 14.8 million of the U.S. population had GI
diseases. Increasing prevalence of GI diseases has boosted the market growth.
Additionally, poor diet and increasing awareness has fuelled the growth of the
market.
Europe is the second leading market across the globe, which
is followed by Asia Pacific. Asia Pacific is the fastest growing market for
Clonorchiasis. Asia Pacific clonorchiasis market is majorly driven by India,
China, and South Korea owing to a huge patient pool, and continuously
developing healthcare sector have fuelled the growth of the market. China has
the largest population of infected people with Clonorchis sinensis.
In 2013, over 13 million people were infected in China.
The Middle East and Africa contribute the least in the
growth of the global clonorchiasis market. However, the Middle East is
dominating the market of this region. The UAE, Saudi Arabia, and Kuwait are
expected to drive the Middle East market. However, Africa holds the least share
of the global market due to limited availability of medical facilities and poor
economic condition. However, the growth of the African market is high due to
the presence of opportunities for the development of the market.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process
of the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment